Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Daewon Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daewon Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Daewon Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Daewon Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daewon Pharmaceutical Co (XKRX:003220) has a OCF Margin % of -2.87% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Daewon Pharmaceutical Co and its competitors. Over the past decade, Daewon Pharmaceutical Co's OCF Margin % has ranged from 1.61 to 13.97. According to the industry distribution chart, Daewon Pharmaceutical Co ranks #635 out of 961 companies in the Drug Manufacturers industry, placing it in the top 66.1%.
Is Daewon Pharmaceutical Co's OCF Margin % too high?
Daewon Pharmaceutical Co's current OCF Margin % is -2.87%. Over the past 10 years, this metric has ranged from a low of 1.61 to a high of 13.97. Based on the distribution chart, Daewon Pharmaceutical Co ranks #635 out of 961 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Daewon Pharmaceutical Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daewon Pharmaceutical Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Daewon Pharmaceutical Co ranks #635 out of 961 companies for OCF Margin %. This places Daewon Pharmaceutical Co in the lower half of its industry. The industry median OCF Margin % is 9.77. Historically, Daewon Pharmaceutical Co's own OCF Margin % has ranged from 1.61 to 13.97 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.77, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Daewon Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daewon Pharmaceutical Co's current OCF Margin % is -2.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daewon Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daewon Pharmaceutical Co (XKRX:003220) is currently considered Significantly Undervalued. The stock's GF Value™ is ₩14,490.07, compared to a current price of ₩7,960.00 — trading 45.1% below its estimated fair value. The current OCF Margin % is -2.87%. Daewon Pharmaceutical Co's overall GF Score™ is 72/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Daewon Pharmaceutical Co (XKRX:003220), the current OCF Margin % is -2.87% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daewon Pharmaceutical Co (XKRX:003220) Overvalued in 2026?
Based on GuruFocus' analysis, Daewon Pharmaceutical Co stock appears to be undervalued.
The current stock price of ₩7,960.00 is trading 45.1% below its estimated GF Value™ of ₩14,490.07.
GuruFocus considers Daewon Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for XKRX:003220:
OCF Margin %: -2.87%
GF Value™: ₩14,490.07 vs. price of ₩7,960.00 (45.1% below fair value)
No single metric tells the full story. See the XKRX:003220 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daewon Pharmaceutical Co Ltd is active in the healthcare sector in Korea. Its main business involves antipyretics, respiratory drugs, cardiovascular drugs, and neuromuscular drugs. It also produces a range of health foods such as multivitamins. The company operates on a global basis.
72GF Score
Get the complete analysis for XKRX:003220
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:003220 has been successfully added to your 
